Hairy cell leukaemia articles from across Nature Portfolio
Hairy cell leukaemia is a sub-type of chronic lymphoid leukaemia and constitutes an uncommon haematological malignancy characterized by an accumulation of abnormal B lymphocytes. The condition gets its name from the fine, hair-like strands that develop around the outside of the cancerous cells.
Latest Research and Reviews
-
-
Research
| Open Access
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial
Leukemia 35, 3314-3318 -
Research
| Open Access
Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up
Blood Cancer Journal 10, 62 -
-
-
Reviews |
New perspectives for targeting RAF kinase in human cancer
Nature Reviews Cancer 17, 676-691
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia
Safety and efficacy of the BRAF inhibitor dabrafenib in relapsed or refractory hairy cell leukemia: a pilot phase-2 clinical trial
Analysis of a cohort of 279 patients with hairy-cell leukemia (HCL): 10 years of follow-up
BRAF inhibitor treatment in classic hairy cell leukemia: a long-term follow-up study of patients treated outside clinical trials
Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience
New perspectives for targeting RAF kinase in human cancer
Hairy cell leukemia expresses programmed death-1
Inside View: Fondation ARC
Hairy cell leukemia cell lines expressing annexin A1 and displaying B-cell receptor signals characteristic of primary tumor cells lack the signature BRAF mutation to reveal unrepresentative origins
A microRNA signature specific for hairy cell leukemia and associated with modulation of the MAPK–JNK pathways